181 related articles for article (PubMed ID: 26138196)
41. Investigating CFTR and KCa3.1 Protein/Protein Interactions.
Klein H; Abu-Arish A; Trinh NT; Luo Y; Wiseman PW; Hanrahan JW; Brochiero E; Sauvé R
PLoS One; 2016; 11(4):e0153665. PubMed ID: 27092946
[TBL] [Abstract][Full Text] [Related]
42. Lack of Kcnn4 improves mucociliary clearance in muco-obstructive lung disease.
Vega G; Guequén A; Philp AR; Gianotti A; Arzola L; Villalón M; Zegarra-Moran O; Galietta LJ; Mall MA; Flores CA
JCI Insight; 2020 Aug; 5(16):. PubMed ID: 32814712
[TBL] [Abstract][Full Text] [Related]
43. Retroviral glycoprotein-mediated immune suppression via the potassium channel K
Laska MJ; Moeller JB; Graversen JH; Strøbæk D; Blomster L; Christophersen P; Bahrami S
Clin Immunol; 2022 Sep; 242():109081. PubMed ID: 35905828
[TBL] [Abstract][Full Text] [Related]
44. KCa3.1 and TRPM7 channels at the uropod regulate migration of activated human T cells.
Kuras Z; Yun YH; Chimote AA; Neumeier L; Conforti L
PLoS One; 2012; 7(8):e43859. PubMed ID: 22952790
[TBL] [Abstract][Full Text] [Related]
45. Role of KCa3.1 Channels in CNS Diseases: A Concise Review.
Sugunan S; Nampoothiri SS; Garg T; Krishnamurthy RG
CNS Neurol Disord Drug Targets; 2016; 15(10):1299-1305. PubMed ID: 27549144
[TBL] [Abstract][Full Text] [Related]
46. Naphtho[1,2-d]thiazol-2-ylamine (SKA-31), a new activator of KCa2 and KCa3.1 potassium channels, potentiates the endothelium-derived hyperpolarizing factor response and lowers blood pressure.
Sankaranarayanan A; Raman G; Busch C; Schultz T; Zimin PI; Hoyer J; Köhler R; Wulff H
Mol Pharmacol; 2009 Feb; 75(2):281-95. PubMed ID: 18955585
[TBL] [Abstract][Full Text] [Related]
47. Protective role of ACE2-Ang-(1-7)-Mas in myocardial fibrosis by downregulating K
Wang LP; Fan SJ; Li SM; Wang XJ; Gao JL; Yang XH
Pflugers Arch; 2016 Nov; 468(11-12):2041-2051. PubMed ID: 27592222
[TBL] [Abstract][Full Text] [Related]
48. Protein histidine phosphatase 1 negatively regulates CD4 T cells by inhibiting the K+ channel KCa3.1.
Srivastava S; Zhdanova O; Di L; Li Z; Albaqumi M; Wulff H; Skolnik EY
Proc Natl Acad Sci U S A; 2008 Sep; 105(38):14442-6. PubMed ID: 18796614
[TBL] [Abstract][Full Text] [Related]
49. Blockage of K(Ca)3.1 and Kv1.3 channels of the B lymphocyte decreases the inflammatory monocyte chemotaxis.
Zhang S; Wang X; Ju C; Zhu L; Du Y; Gao C
Int Immunopharmacol; 2016 Feb; 31():266-71. PubMed ID: 26795234
[TBL] [Abstract][Full Text] [Related]
50. miR-497-5p inhibits cell proliferation and invasion by targeting KCa3.1 in angiosarcoma.
Chen Y; Kuang D; Zhao X; Chen D; Wang X; Yang Q; Wan J; Zhu Y; Wang Y; Zhang S; Wang Y; Tang Q; Masuzawa M; Wang G; Duan Y
Oncotarget; 2016 Sep; 7(36):58148-58161. PubMed ID: 27531900
[TBL] [Abstract][Full Text] [Related]
51. The calcium-activated potassium channel KCa3.1 is an important modulator of hepatic injury.
Sevelsted Møller L; Fialla AD; Schierwagen R; Biagini M; Liedtke C; Laleman W; Klein S; Reul W; Koch Hansen L; Rabjerg M; Singh V; Surra J; Osada J; Reinehr R; de Muckadell OB; Köhler R; Trebicka J
Sci Rep; 2016 Jun; 6():28770. PubMed ID: 27354175
[TBL] [Abstract][Full Text] [Related]
52. Modulators of small- and intermediate-conductance calcium-activated potassium channels and their therapeutic indications.
Wulff H; Kolski-Andreaco A; Sankaranarayanan A; Sabatier JM; Shakkottai V
Curr Med Chem; 2007; 14(13):1437-57. PubMed ID: 17584055
[TBL] [Abstract][Full Text] [Related]
53. TRPC1 regulates fMLP-stimulated migration and chemotaxis of neutrophil granulocytes.
Lindemann O; Strodthoff C; Horstmann M; Nielsen N; Jung F; Schimmelpfennig S; Heitzmann M; Schwab A
Biochim Biophys Acta; 2015 Sep; 1853(9):2122-30. PubMed ID: 25595528
[TBL] [Abstract][Full Text] [Related]
54. Functional expression of mitochondrial K
Bulk E; Todesca LM; Bachmann M; Szabo I; Rieke M; Schwab A
Pflugers Arch; 2022 Nov; 474(11):1147-1157. PubMed ID: 36152073
[TBL] [Abstract][Full Text] [Related]
55. The KCa3.1 blocker TRAM-34 inhibits proliferation of fibroblasts in paraquat-induced pulmonary fibrosis.
Xie H; Lu J; Zhu Y; Meng X; Wang R
Toxicol Lett; 2018 Oct; 295():408-415. PubMed ID: 30036685
[TBL] [Abstract][Full Text] [Related]
56. Functional role of the KCa3.1 potassium channel in synovial fibroblasts from rheumatoid arthritis patients.
Friebel K; Schönherr R; Kinne RW; Kunisch E
J Cell Physiol; 2015 Jul; 230(7):1677-88. PubMed ID: 25545021
[TBL] [Abstract][Full Text] [Related]
57. Histone Deacetylases Enhance Ca
Matsui M; Terasawa K; Kajikuri J; Kito H; Endo K; Jaikhan P; Suzuki T; Ohya S
Int J Mol Sci; 2018 Sep; 19(10):. PubMed ID: 30262728
[TBL] [Abstract][Full Text] [Related]
58. The Ca2+-activated K+ channel KCNN4/KCa3.1 contributes to microglia activation and nitric oxide-dependent neurodegeneration.
Kaushal V; Koeberle PD; Wang Y; Schlichter LC
J Neurosci; 2007 Jan; 27(1):234-44. PubMed ID: 17202491
[TBL] [Abstract][Full Text] [Related]
59. K
Lu R; Flauaus C; Kennel L; Petersen J; Drees O; Kallenborn-Gerhardt W; Ruth P; Lukowski R; Schmidtko A
Neuropharmacology; 2017 Oct; 125():386-395. PubMed ID: 28823609
[TBL] [Abstract][Full Text] [Related]
60. K⁺-channel inhibition reduces portal perfusion pressure in fibrotic rats and fibrosis associated characteristics of hepatic stellate cells.
Freise C; Heldwein S; Erben U; Hoyer J; Köhler R; Jöhrens K; Patsenker E; Ruehl M; Seehofer D; Stickel F; Somasundaram R
Liver Int; 2015 Apr; 35(4):1244-52. PubMed ID: 25212242
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
